Jazz Pharmaceuticals plc - JAZZ
About Gravity Analytica
Recent News
- 06.10.2025 - Zepzelca ASCO Data Webcast
- 06.10.2025 - Zepzelca ASCO Data Webcast
- 05.06.2025 - Jazz Pharmaceuticals 2025 First Quarter Earnings
- 05.06.2025 - Jazz Pharmaceuticals 2025 First Quarter Earnings
- 05.06.2025 - Jazz Pharmaceuticals 2025 First Quarter Earnings
- 05.06.2025 - Jazz Pharmaceuticals 2025 First Quarter Earnings
- 04.25.2025 - Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
- 04.25.2025 - Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
- 04.23.2025 - Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
- 04.23.2025 - Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Recent Filings
- 04.25.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
- 04.21.2025 - 8-K Current report
- 04.21.2025 - EX-99.1 EX-99.1
- 04.18.2025 - SC TO-T/A Tender offer statement by Third Party
- 04.14.2025 - SC TO-T/A Tender offer statement by Third Party
- 04.11.2025 - SC TO-T/A Tender offer statement by Third Party